Sort
48,018 grants matching “immunotherapy”
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES
$668,366Massimo T Pietropaolo · Baylor College Of Medicine · R01 · FY2017 · DK
Immune Dysregulation by Human Papillomavirus during Head and Neck Cancer Progression
$668,326Dohun Pyeon · Michigan State University · R01 · FY2018 · DE
Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis
$668,277Ellen M. Mowry · Johns Hopkins University · R01 · FY2024 · NR
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
$668,272Lyle L Moldawer · University Of Florida · R01 · FY2019 · HD
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$668,212Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Immunotherapy of Uveal Melanoma using PRAME Vaccine in Combination with Adoptive T Cell Therapy
$668,196Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$668,154Benjamin G. Neel · New York University School Of Medicine · R01 · FY2024 · CA
Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy
$668,129Richard Leo Wahl · Johns Hopkins University · U01 · FY2012 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$668,089Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
$668,053Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$668,028Harvinder Singh Gill · Texas Tech University · R01 · FY2023 · AI
Dual-isotope SPECT imaging and immunophenotyping of immune cells to determine response to immunotherapy
$668,018Harriet M Kluger · Yale University · R01 · FY2023 · CA
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$667,996Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2024 · CA
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
$667,911Adam Goode · Duke University · R01 · FY2024 · AR
Antibodies, B cells and resistance to human cryptococcosis
$667,846Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Regulation of human dendritic cell activation
$667,843Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$667,798Warren J Leonard · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
$667,761Meenakshi G Hegde · Baylor College Of Medicine · R01 · FY2023 · CA
Dissecting the role of CD8+ T cells in atherosclerosis
$667,760Chiara Giannarelli · New York University School Of Medicine · R01 · FY2022 · HL
Identifying mechanisms of tissue injury in MS lesions: a multi-modality imaging approach
$667,748Susan A Gauthier · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · NS
Targeted Lymphoablation as an alternative to HSCT to cure T1D
$667,733Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2022 · DK
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$667,694Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
$667,638Isaac P Thomsen · Vanderbilt University Medical Center · R01 · FY2019 · AI
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
$667,601Yaqing Zhang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Th9 cells and protective TB immunity
$667,594Daniel F. Hoft · Saint Louis University · R01 · FY2023 · AI